Brainreader Aps
DenmarkFDA applicant, unverified
Brainreader Aps is a medical device manufacturer, with 8 devices listed in FDA GUDID and FDA 510(k) (FDA Class II) and 1 FDA recall as of 16 Nov 2026.
- Devices
- 8
- FDA recalls
- 1
Registry facts
- Registries
- FDA GUDID 7
- FDA 510(k) 1
- Device classes
- FDA Class II 8
- FDA recalls
- Identifiers
- DUNS 305279427
At a glance
Market reach
- United States
- FDA recalls
What Brainreader Aps makes
Brainreader Aps develops software applications focused on image segmentation for medical imaging, specifically designed for neurological analysis. Their primary product, Neuroreader, specializes in processing and interpreting brain scans to assist in diagnostic workflows, including automated segmentation of neuroanatomical structures.
The company’s portfolio is regulated under Class II medical devices in the United States, with authorisations granted through FDA pathways including 510(k) submissions and the Unique Device Identifier (UDI) system. Their products are listed in the FDA’s regulatory databases, ensuring compliance with U.S. medical device regulations.
Catalogue
- Regimes: 510(k) Registry: GUDID
- Regimes: 510(k) Registry: GUDID
- Regimes: 510(k) Registry: GUDID
- Regimes: 510(k) Registry: GUDID
- Regimes: 510(k) Registry: GUDID
- Regimes: 510(k) Registry: GUDID
- Regimes: 510(k) Registry: GUDID
Neuroreader Medical Image Processing Software Ref K140828
Regimes: 510(k) Registry: 510(k)
Company details
- DUNS number
- 305279427
- Phone
- +4553524749
FDA recalls
FDA recall records list 1 recall initiated by Brainreader Aps, initiated on 2020-12-14. By recorded status: 1 terminated. The reasons filed fall into these groups: other reasons as filed. A recall is often a precaution started by the manufacturer, and a count of records is not a verdict on a company.
Recalls initiated per year
- 2017 0
- 2018 0
- 2019 0
- 2020 1
- 2021 0
- 2022 0
- 2023 0
- 2024 0
- 2025 0
- 2026 0
2020
- 14 Dec 2020 Z-0934-2021 Class II Terminated The Neuroreader has been distributed with a reference
normative database that is different from the version reviewed and cleared by FDA.
Full distribution text
- 14 Dec 2020 Z-0934-2021 Class II Terminated The Neuroreader has been distributed with a reference
normative database that is different from the version reviewed and cleared by FDA.
Frequently asked questions
How many devices does Brainreader Aps have in the registry?
The registry currently lists 8 devices for Brainreader Aps. Devices recorded under merged duplicate company entries are counted once.
Which registries list Brainreader Aps's devices?
Among its 8 most recently registered devices, Brainreader Aps has devices listed in FDA 510(k) (1 device) and FDA GUDID (7 devices). A device can be listed in more than one registry, so these counts overlap.
What risk classes do Brainreader Aps's devices fall under?
Among its 8 most recently registered devices, the classes recorded for Brainreader Aps's devices are Class II. Each device page shows its own class and authorisation.
Are there FDA recall records for Brainreader Aps?
FDA recall records list 1 recall initiated by Brainreader Aps, the most recent initiated on 14 Dec 2020. A recall is often a precaution started by the manufacturer; the records say nothing about the company's overall record.
What are the newest devices from Brainreader Aps in the registry?
The most recently registered devices listed for Brainreader Aps include Neuroreader 2.4, Neuroreader 2.6, Neuroreader 2.2.8 and Neuroreader 2.5.